II. Class
- Anticonvulsant
III. Indications: Adjunctive Therapy
- Simple Partial Seizure
- Complex Partial Seizure
- Bipolar Disorder (not FDA approved)
V. Adverse Effects: Other
- Nonconvulsive Status Epilepticus
VI. Precautions
- Adjust dose in hepatic disease
VII. Dose: Adults and children over age 12
- Initial: 4 mg PO qd for first week
- Increase by 4-8 mg increments per day weekly
- Divide daily dose to bid-qid after first week
- Maximum: 56 mg/day divided bid-qid
Images: Related links to external sites (from Bing)
Related Studies
| tiagabine (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
| TIAGABINE HCL 4 MG TABLET | Generic | $3.24 each |
| gabitril (on 1/1/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
| GABITRIL 4 MG TABLET | Generic | $3.24 each |